Flix 50 mcg / dose nasal spray 20 ml

Tradename

Flix

Composition

Each spray dose contains:

Fluticasone propionate 50 mcg

Auxiliary components:

dextrose, avicel RC591 (microcrystalline cellulose, sodium carmellose), phenylethanol, benzalkonium chloride, polysorbate, hydrochloric acid, purified water.

Properties

GCS for intranasal use. It has a pronounced anti-inflammatory effect. With intranasal administration, there is no systemic effect, practically does not inhibit the hypothalamicpituitary-adrenal system.

The anti-inflammatory effect of fluticasone propionate is realized as a result of its interaction with glucocorticoid receptors. Suppresses the proliferation of mast cells, eosinophils, lymphocytes, macrophages, neutrophils. Fluticasone propionate reduces the production of inflammatory mediators and a number of biologically active substances (including histamine, prostaglandins, leukotrienes, cytokines) during the early and late phases of an allergic reaction. Has a fast anti-inflammatory effect on the nasal mucosa. Antiallergic effect appears within 2-4 hours after the first application. Reduces sneezing, itchy nose, rhinorrhea, nasal congestion, sinus discomfort and pressure around nose and eyes. In addition, it relieves eye symptoms associated with allergic rhinitis.

Indications

Treatment of perennial and seasonal allergic rhinitis, including hay fever (hay fever): — pain, feeling of pressure in the paranasal sinuses; nasal congestion, sneezing, itching in the nose; — lacrimation.

Method of administration and dosage:

Adults and children over 12 years old:

Contraindications

-increased sensitivity to fluticasone propionate

and other components of the drug;

children up to 4 years old;

Side effects

From the nervous system: often — headache, a feeling of unpleasant taste and smell. Headache, unpleasant taste and odor have also been reported with other nasal sprays.

From the respiratory system: very often epistaxis; often — dryness of the mucous membrane in the nasal cavity and pharynx, irritation of the mucous membrane in the nasal cavity and pharynx (these adverse reactions, as well as nosebleeds were observed when using other intranasal.

Storage method: